Hemavant Sciences GmbH

The company aims to acquire, develop and market biopharmaceutical products. The company may enter into any business and conclude contracts that are suitable to promote the purpose of the company, or that are directly or indirectly related to it. The company may participate in other companies or merge with them. The company may acquire, hold and sell real estate. It may establish branches and agencies in Switzerland and abroad by decision of the Board of Directors. The company may grant loans or other financing to its direct or indirect parent companies and their direct or indirect subsidiaries, for consideration or free of charge, and provide security of any kind for the liabilities of such group companies, including guarantees, pledges and fiduciary transfers of assets of the companies.